Project Information

Unit Code

Financing Institution

Lead

Project Title

Search

Code	Project Title	Financing Institution	Lead	Year of Project Start
	An Assessment of nutritional status and eating patterns for children under 2-years old with cow’s milk protein allergy.	NUTRICIA FOUNDATION	dr Piotr Dziechciarz
	Early and very early nutrition in acute pancreatitis	NUTRICIA FOUNDATION	dr hab. Aleksandra Banaszkiewicz
	Effect of iron supplementation on psychomotor development of non-anemic exclusively or predominantly breastfed infants: randomized, controlled trial.	NUTRICIA FOUNDATION	dr Anna Chmielewska
	CureGN: Glomerulonephropathy Network.	National Institute of Health/University of Columbia	dr hab. n. med. Krzysztof Mucha
	Education of doctors in the field of vaccination of children with autism spectrum disorders	GlaxoSmithKline	lek. Anna Piwowarczyk
	Use of anti-CD19 CAR-T lymphocytes in the treatment of adult patients with relapsed and refractory acute lymphoblastic leukemia. Phase I / II clinical trial	Medical Research Agency	prof. dr hab. Grzegorz Basak
	Evaluation of the efficacy and safety of Nebivolol in the treatment of hypertension in adolescents	Medical Research Agency	dr hab. Małgorzata Pańczyk-Tomaszewska
	Multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rapamycin in drug-resistant epilepsy associated with tuberous sclerosis	Medical Research Agency	prof. dr hab. n. med. Sergiusz Jóźwiak
	EMpagliflozin and daPAgliflozin in patients hospiTalized for acute decompensated Heart failure (EMPATHY trial)	Medical Research Agency	Prof. dr hab. Marek Postuła Prof. dr hab. Jolanta Siller-Matula
	Randomized, double-blind clinical trial evaluating the safety and efficacy of rapamycin versus vigabatrin in the prophylactic treatment of infants with tuberous sclerosis	Medical Research Agency	prof. dr hab. Sergiusz Jóźwiak
	Assessment of the safety and efficacy of an advanced therapy medicinal product containing living ASCs in the treatment of diabetic foot syndrome - a randomized, double-blind study (FootCell)	Medical Research Agency	prof. dr hab. n. med. Małgorzata Lewandowska-Szumieł
	Phase 2a non-commercial and non-randomized intervention study. evaluating the effectiveness of crizotinib in the treatment of children with severe form of neurofibromatosis type 2, in particular those who cannot undergo surgery and radiotherapy	Medical Research Agency	dr n. med. Marek Karwacki
	Assessment of the frequency of persistent pulmonary hypertension of newborns in the group of newborns born between 32nd and 42th week of pregnancy treated with salbutamol	Medical Research Agency	dr hab. n. med. Renata Bokiniec
	A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)	Medical Research Agency	Kierownik Projektu - dr n. med. Krzysztof Ozierański, Główny Badacz - prof. dr hab. Marcin Grabowski
	Incidence of SARS-CoV-2 infections among police employees in Mazowieckie province - representative epidemiological study	Medical Research Agency	prof. dr hab. Mariusz Gujski
	Use of targeted therapy in children from 3 to 18 years of age with the diagnosis of diffuse intrinsic pontine glioma-DIPG based on the results of DIPGen genetic tests	Medical Research Agency	prof. dr hab. Rafał Płoski
	Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)	Medical Research Agency	dr Aleksandra Gąsecka - van der Pol
	A multicentre, randomized, double-blind, placebo-controlled clinical trial evaluating the effect of intestinal microbiota transplantation as an inflammatory response modulator (immunomodulation), included in standard therapy	Medical Research Agency	dr n. med. Jarosław Biliński
	Evaluation of the efficacy and safety of empagliflozin in the treatment of neutropenia in patients with glycogenosis 1b "- EMPAtia	Medical Research Agency	dr Piotr Sobieraj
	Polish Chimeric Antigen Receptor T-cell Network	Medical Research Agency	dr hab. n. med. Radosław Zagożdżon (Kierownik Projektu) / prof. dr hab. Sebastian Giebel (Główny Badacz)